Voxelotor is a hemoglobin S polymerization inhibitor indicated for the treatment of sickle cell disease, where it functions by increasing hemoglobin’s affinity for oxygen to prevent red blood cell sickling.… Read more
Voxelotor is a hemoglobin S polymerization inhibitor indicated for the treatment of sickle cell disease, where it functions by increasing hemoglobin’s affinity for oxygen to prevent red blood cell sickling. This category provides essential materials for pharmaceutical research and rigorous quality control, including high-purity reference standards of the active pharmaceutical ingredient, its pharmacopeial and non-pharmacopeial impurities, and stable isotope labelled compounds. Laboratories utilize these reference standards to conduct precise impurity profiling and support method validation during drug development. Stable isotope labelled compounds, such as deuterium-labelled variants, serve as critical internal standards for accurate quantitative analysis in mass spectrometry and pharmacokinetic studies. By supplying these well-characterized substances, this collection supports the development of reliable analytical methods and ensures adherence to regulatory standards throughout the lifecycle of the drug.